Key indicators: single-crystal X-ray study; T = 100 K; mean (C-C) = 0.002 Å; R factor = 0.030; wR factor = 0.086; data-to-parameter ratio = 15.6.
Related literature
For the biological activity of uracil and pyrimidine derivatives see: Ding et al. (2006) ; Hawser et al., (2006) ; Brunelle et al. (2011) . For related uracil structures, see: Tiekink (1989) ; Nasir et al. (2010) ; El-Emam et al. (2011) .
Experimental
Crystal data Refinement R[F 2 > 2(F 2 )] = 0.030 wR(F 2 ) = 0.086 S = 1.03 2102 reflections 135 parameters 2 restraints H atoms treated by a mixture of independent and constrained refinement Á max = 0.27 e Å À3 Á min = À0.28 e Å À3 Table 1 Hydrogen-bond geometry (Å , ). (14) 168 (2) Symmetry codes: (i) Àx þ 1; y; Àz þ 1 2 ; (ii) Àx þ 1; y; Àz þ 3 2 .
Data collection: CrysAlis PRO (Agilent, 2011); cell refinement: CrysAlis PRO; data reduction: CrysAlis PRO; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008) ; program(s) used to refine structure: SHELXL97 (Sheldrick, 2008) ; molecular graphics: ORTEP-3 (Farrugia, 1997) and DIAMOND (Brandenburg, 2006) ; software used to prepare material for publication: publCIF (Westrip, 2010) .
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Comment
The chemotherapeutic efficacy of uracil derivatives is related to their ability to inhibit vital enzymes responsible for DNA biosynthesis. Thus, several uracil and pyrimidine non-nucleoside derivatives exhibited anti-cancer (Al-Safarjalani et al., 2005 ), anti-viral (Brunelle et al., 2007 Ding et al., 2006) and anti-bacterial activities (Hawser et al., 2006; Al-Abdullah et al., 2011) . In continuation to our interest in the chemical and pharmacological properties of uracil and pyrimidine derivatives (Al-Omar et al., 2010; Al-Turkistani et al., 2011) , and as part of on-going structural studies of uracil and pyrimidine derivatives (Nasir et al., 2010; El-Emam et al. 2011) , we synthesized the title compound 6-(2-methylpropyl)-2-thiouracil-5-carbonitrile (I) as a precursor for potential chemotherapeutic agents.
The thiouracil derivative (I), Fig. 1 , exists in the thione form with the C1═S1 bond length of 1.6693 (13) Å being shorter than the equivalent bond in the parent 2-thiouracil compound, i.e. 1.683 (3) Å (Tiekink, 1989) 
Experimental
A mixture of 3-methylbutanal (8.61 g, 0.1 mol), ethyl cyanoacetate (11.31 g, 0.1 mol), thiourea (7.61 g, 0.1 mol) and potassium carbonate (13.8 g, 0.1 mol) was heated in in ethanol (300 ml) under reflux for 6 h. On cooling, the separated precipitate was filtered, washed with diethyl ether and dried. The obtained solid was added to water (200 ml) and the mixture was heated at 283-293 K until a clear solution was obtained. The solution was acidified with acetic acid and stirred for 30 min. The deposited precipitate was filtered, washed with cold water, dried and crystallized from acetic acid to yield 5.86 g (28%) of the title compound (I) as colourless crystals. m.p. 545-547. 1 H NMR (DMSO-d6): δ 1.07 (d, 6H, CH 3 , J = 6.5 Hz), 2.18-2.24 (m, 1H, CH), 2.68 (d, 2H, CH 2 , J = 6.5 Hz), 13.08 (br. s, 2H, NH). 13 C NMR: δ 21.50 (CH 3 ), 29.40 (CH), 40.30 (CH 2 ), 92.30 (Uracil C-5), 114.80 (CN), 158.60 (C═O), 163.90 (Uracil C-6), 176.75 (C═S).
Refinement
Carbon-bound H atoms were placed in calculated positions [C-H = 0.95 to 1.00 Å, U iso (H) = 1.2-1.5U eq (C)] and were included in the refinement in the riding model approximation. The amide H atoms were located in a difference Fourier map, and were refined with a distance restraint of N-H = 0.88±0.01 Å; their U iso values were refined. 
Computing details
Data collection: CrysAlis PRO (Agilent, 2011) ; cell refinement: CrysAlis PRO (Agilent, 2011) ; data reduction: CrysAlis PRO (Agilent, 2011) ; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008) ; program(s) used to refine structure: SHELXL97 (Sheldrick, 2008) ; molecular graphics: ORTEP-3 (Farrugia, 1997) and DIAMOND (Brandenburg, 2006) ; software used to prepare material for publication: publCIF (Westrip, 2010) .
Figure 1
The molecular structure of (I) showing the atom-labelling scheme and displacement ellipsoids at the 50% probability level. Special details Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes. Refinement. Refinement of F 2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F 2 , conventional R-factors R are based on F, with F set to zero for negative F 2 . The threshold expression of F 2 > σ(F 2 ) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F 2 are statistically about twice as large as those based on F, and R-factors based on ALL data will be even larger.
Figure 2
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å 2 )
x y z U iso */U eq S1 0.550100 (11) (6) 0.0186 (6) −0.0003 (4) 0.0009 (5) 0.0006 (4) C5 0.0165 (6) 0.0168 (6) 0.0152 (5) 0.0002 (5) −0.0014 (4) −0.0016 (4) C6 0.0150 (6) 0.0183 (7) 0.0152 (6) 0.0013 (4) −0.0012 (5) −0.0003 (4) C7 0.0122 (5) 0.0193 (6) 0.0162 (5) 0.0005 (4) 0.0011 (4) −0.0028 (5) C8 0.0230 (7) 0.0251 (7) 0.0224 (6) 0.0030 (5) −0.0075 (5) −0.0055 (5) C9 0.0201 (6) 0.0233 (7) 0.0224 (6) −0.0050 (5) 0.0014 (5) 0.0004 (5) Geometric parameters (Å, º) S1-C1 1.6693 (13) C6-C7 1.5486 (17) (17) 
